Tuesday, August 26, 2014

ANA patterns - list from fpnotebook

II. Homogenous Pattern

  1. Systemic Lupus Erythematosus (Very specific)
  2. Further evaluation
    1. Anti-dsDNA
    2. Anti-ssDNA
    3. Anti-Smith

III. Speckled Pattern

  1. Most common, least specific
  2. Disorders
    1. Systemic Lupus Erythematosus
    2. Mixed Connective Tissue Disease
    3. Scleroderma
    4. Sjogren's Syndrome
  3. Further evaluation
    1. Smith Antibody (Anti-Smith)
    2. Ribonucleoprotein Antibody (Anti-RNP)
    3. Scl-70 kD kinetochore (Anti-Topoisomerase I)
    4. Anti-La (Anti-SSB)

IV. Nucleolar Pattern

  1. Disorders
    1. Scleroderma
    2. CREST syndrome
  2. Further evaluation
    1. Scl-70 kD kinetochore (Anti-Topoisomerase I)
    2. PM-1

V. Diffuse Pattern

  1. Non-specific pattern

VI. Centromere Pattern

  1. Seen in PSS with CREST syndrome

Wednesday, August 6, 2014

1998 Consensus Criteria for FTD (Neary et al)

http://www.neurology.org/content/51/6/1546.full#sec-3

The clinical criteria are set out in lists 1 through 4. The criteria for each of the three major clinical syndromes are divided into sections. The clinical profile statement together with the core clinical inclusion and exclusion features provide the necessary foundation for diagnosis. Additional clinical features, neuropsychological investigation, and brain imaging support the clinical diagnosis. Operational definitions of specific features are outlined later. 

Clinical profile. This statement (seen in lists 1 through 3) summarizes the neurobehavioral profile necessary to fulfill criteria for diagnosis. 

Core diagnostic features. These are features (see lists 1 through 3) integral to the clinical syndrome. All features must be present to fulfill the criteria for diagnosis. 

Supportive diagnostic features. 
Clinical. These are features (see lists 1 through 3) that are not present in all patients, or they may be noted only during one phase of the disease. They are therefore not necessary conditions for diagnosis. Supportive features are characteristic, often with high diagnostic specificity, and their presence adds substantial weight to the clinical diagnosis. The diagnosis becomes more likely when more supportive features are present.
Physical. In each of the clinical syndromes physical signs are few in contrast to the prominent mental changes. Parkinsonian signs typically emerge only during late disease. The physical features outlined should be regarded as "supportive" rather than as necessary conditions for diagnosis.
Investigations. Formal neuropsychological assessment, EEG, and brain imaging each can provide support for and strengthen the clinical diagnosis. Such investigatory techniques are not available universally, and ought not to be considered a prerequisite for diagnosis. When neuropsychological assessment is performed, the profile of deficits must demonstrate disproportionate executive dysfunction in FTD or disproportionate language/semantic breakdown in PA and SD. With regard to brain imaging, the patterns of abnormality are characteristic, but not seen invariably. For example, prominent atrophy of the temporal lobes is well visualized by high-resolution MRI, but may be undetected by CT. Failure to demonstrate the prototypic appearances on imaging need not result in diagnostic exclusion.

Supportive features common to each of the clinical syndromes. These features (see list 4) support but are not a necessary condition for FTLD. Onset of disease is most commonly before the age of 65 years, although rare examples of onset in the very elderly have been reported. A positive family history of a similar disorder in a first-degree relative has been reported2,4 in as many as 50% of patients: Some families have shown mutations on chromosome 17 or linkage to chromosome 3. Motor neuron disease is a recognized albeit uncommon accompaniment to the clinical syndromes of lobar degeneration.42-47 The development of motor neuron disease in patients presenting with a progressive behavioral or language disorder would strongly support a clinical diagnosis of FTD or PA respectively.

Exclusion features common to each clinical syndrome.  
Clinical. All features (see list 4) must be absent. Early severe amnesia, early spatial disorientation, logoclonic speech with loss of train of thought, and myoclonus are features designed to exclude AD.
Investigations. All features should be absent (when the relevant information is available).

Relative diagnostic exclusion features. These are features (see list 4) that caution against but do not firmly exclude a diagnosis of FTLD. A history of alcohol abuse raises the possibility of an alcohol-related basis for a frontal lobe syndrome. However, excessive alcohol intake may also occur in FTD patients as a secondary manifestation of social disinhibition or hyperoral tendencies. The presence of vascular risk factors such as hypertension ought to alert investigators to a possible vascular etiology. Nevertheless, such risk factors are common in the general population and may be present coincidentally in some patients with FTLD, particularly in those of more advanced age.


List 1 The clinical diagnostic features of FTD: Clinical profile
Character change and dirordered social conduct are the dominant features initially and throughout the disease course. Instrumental functions of perception, spatial skills, praxis, and memory are intact or relatively well preserved.

  1. Core diagnostic features



  2. Insidious onset and gradual progression

  3. Early decline in social interpersonal conduct

  4. Early impairment in regulation of personal conduct

  5. Early emotional blunting

  6. Early loss of insight


  7. Supportive diagnostic features



  8. Behavioral disorder




    1. Decline in personal hygiene and grooming

    2. Mental rigidity and inflexibility

    3. Distractibility and impersistence

    4. Hyperorality and dietary changes

    5. Perseverative and stereotyped behavior

    6. Utilization behavior



  9. Speech and language




    1. Altered speech output




      1. Aspontaneity and economy of speech

      2. Press of speech



    2. Stereotype of speech

    3. Echolalia

    4. Perseveration

    5. Mutism



  10. Physical signs




    1. Primitive reflexes

    2. Incontinence

    3. Akinesia, rigidity, and tremor

    4. Low and labile blood pressure



  11. Investigations




    1. Neuropsychology: significant impairment on frontal lobe tests in the absence of severe amnesia, aphasia, or perceptuospatial disorder

    2. Electroencephalography: normal on conventional EEG despite clinically evident dementia

    3. Brain imaging (structural and/or functional): predominant frontal and/or anterior temporal abnormality



List 2 The clinical diagnostic features of progressive nonfluent aphasia: Clinical profile

Disorder of expressive language is the dominant feature initially and throughout the disease course. Other aspects of cognition are intact or relatively well preserved.




  1. Core diagnostic features



  2. Insidious onset and gradual progression

  3. Nonfluent spontaneous speech with at least one of the following: agrammatism, phonemic paraphasias, anomia


  4. Supportive diagnostic features



  5. Speech and language




    1. Stuttering or oral apraxia

    2. Impaired repetition

    3. Alexia, agraphia

    4. Early preservation of word meaning

    5. Late mutism



  6. Behavior




    1. Early preservation of social skills

    2. Late behavioral changes similar to FTD



  7. Physical signs: late contralateral primitive reflexes, akinesia, rigidity, and tremor

  8. Investigations




    1. Neuropsychology: nonfluent aphasia in the absence of severe amnesia or perceptuospatial disorder

    2. Electroencephalography: normal or minor asymmetric slowing

    3. Brain imaging (structural and/or functional): asymmetric abnormality predominantly affecting dominant (usually left) hemisphere






List 3 The clinical diagnostic features of semantic aphasia and associative agnosia (SD): Clinical profile

Semantic disorder (impaired understanding of word meaning and/or object identity) is the dominant feature initially and throughout the disease course. Other aspects of cognition, including autobiographic memory, are intact or relatively well preserved.




  1. Core diagnostic features



  2. Insidious onset and gradual progression

  3. Language Disorder characterized by




    1. Progressive, fluent, empty spontaneous speech

    2. Loss of word meaning, manifest by impaired naming and comprehension

    3. Semantic paraphasias and/or



  4. Perceptual disorder characterized by




    1. Prosopagnosia: impaired recognition of identity of familiar faces and/or

    2. Associative agnosia: impaired recognition of object identity



  5. Preserved perceptual matching and drawing reproduction

  6. Preserved single-word repetition

  7. Preserved ability to read aloud and write to dictation orthographically regular words


  8. Supportive diagnostic features



  9. Speech and language




    1. Press of speech

    2. Idiosyncratic word usage

    3. Absence of phonemic paraphasias

    4. Surface dyslexia and dysgraphia

    5. Preserved calculation



  10. Behavior




    1. Loss of sympathy and empathy

    2. Narrowed preoccupations

    3. Parsimony



  11. Physical signs




    1. Absent or late primitive reflexes

    2. Akinesia, rigidity, and tremor



  12. Investigations

  13. Neuropsychology




    1. Profound semantic loss, manifest in failure of word comprehension and naming and/or face and object recognition

    2. Preserved phonology and syntax, and elementary perceptual processing, spatial skills, and day-to-day memorizing



  14. Electroencephalography: normal

  15. Brain imaging (structural and/or functional): predominant anterior temporal abnormality (symmetric or asymmetric)


List 4 Features common to clinical syndromes of FTLD (extension of lists 1 through 3)
III. Supportive features


  • Onset before 65 years: positive family history of similar disorder in first-degree relative



  • Bulbar palsy, muscular weakness and wasting, fasciculations (associated motor neuron disease present in a minority of patients)



  • IV. Diagnostic exclusion features





  • Historical and clinical




    1. Abrupt onset with ictal events

    2. Head trauma related to onset

    3. Early, severe amnesia

    4. Spatial disorientation

    5. Logoclonic, festinant speech with loss of train of thought

    6. Myoclonus

    7. Corticospinal weakness

    8. Cerebellar ataxia

    9. Choreoathetosis





  • Investigations




    1. Brain imaging: predominant postcentral structural or functional deficit; multifocal lesions on CT or MRI

    2. Laboratory tests indicating brain involvement of metabolic or inflammatory disorder such as MS, syphilis, AIDS, and herpes simplex encephalitis





  • V. Relative diagnostic exclusion features





  • Typical history of chronic alcoholism



  • Sustained hypertension



  • History of vascular disease (e.g., angina, claudication)
  • 2011 FTD Consortium Criteria (FTDC) for bvFTD


    International consensus criteria for behavioural variant FTD (FTDC)
    I. Neurodegenerative disease
    The following symptom must be present to meet criteria for bvFTD
         A. Shows progressive deterioration of behaviour and/or cognition by observation or history (as provided by a knowledgeable informant).
    II. Possible bvFTD
    Three of the following behavioural/cognitive symptoms (A–F) must be present to meet criteria. Ascertainment requires that symptoms be persistent or recurrent, rather than single or rare events.
        A. Early* behavioural disinhibition [one of the following symptoms (A.1–A.3) must be present]:
                A.1. Socially inappropriate behaviour
                A.2. Loss of manners or decorum
                A.3. Impulsive, rash or careless actions
        B. Early apathy or inertia [one of the following symptoms (B.1–B.2) must be present]:
                B.1. Apathy
                B.2. Inertia
        C. Early loss of sympathy or empathy [one of the following symptoms (C.1–C.2) must be present]:
                C.1. Diminished response to other people’s needs and feelings
                C.2. Diminished social interest, interrelatedness or personal warmth
         D. Early perseverative, stereotyped or compulsive/ritualistic behaviour [one of the following symptoms (D.1–D.3) must be present]:
                D.1. Simple repetitive movements
                D.2. Complex, compulsive or ritualistic behaviours
                D.3. Stereotypy of speech
        E. Hyperorality and dietary changes [one of the following symptoms (E.1–E.3) must be present]:
                E.1. Altered food preferences
                E.2. Binge eating, increased consumption of alcohol or cigarettes
                E.3. Oral exploration or consumption of inedible objects
         F. Neuropsychological profile: executive/generation deficits with relative sparing of memory and visuospatial functions [all of the following symptoms (F.1–F.3) must be present]:
                F.1. Deficits in executive tasks
                F.2. Relative sparing of episodic memory
                F.3. Relative sparing of visuospatial skills
    III. Probable bvFTD
    All of the following symptoms (A–C) must be present to meet criteria.
        A. Meets criteria for possible bvFTD
         B. Exhibits significant functional decline (by caregiver report or as evidenced by Clinical Dementia Rating Scale or Functional Activities Questionnaire scores)
        C. Imaging results consistent with bvFTD [one of the following (C.1–C.2) must be present]:
                C.1. Frontal and/or anterior temporal atrophy on MRI or CT
                C.2. Frontal and/or anterior temporal hypoperfusion or hypometabolism on PET or SPECT
    IV. Behavioural variant FTD with definite FTLD Pathology
    Criterion A and either criterion B or C must be present to meet criteria.
        A. Meets criteria for possible or probable bvFTD
        B. Histopathological evidence of FTLD on biopsy or at post-mortem
        C. Presence of a known pathogenic mutation
    V. Exclusionary criteria for bvFTD
    Criteria A and B must be answered negatively for any bvFTD diagnosis. Criterion C can be positive for possible bvFTD but must be negative for probable bvFTD.
        A. Pattern of deficits is better accounted for by other non-degenerative nervous system or medical disorders
        B. Behavioural disturbance is better accounted for by a psychiatric diagnosis
        C. Biomarkers strongly indicative of Alzheimer’s disease or other neurodegenerative process
    *As a general guideline ‘early’ refers to symptom presentation within the first 3 years

    Tuesday, August 5, 2014

    Corneomandibular reflex

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC108345

    Seven patients are presented in whom a prominent corneomandibular reflex was observed. These patients all had severe cerebral and/or brain-stem disease with altered states of consciousness. Two additional patients with less prominent and inconsistent corneomandibular reflexes were seen; one had bulbar amyotrophic lateral sclerosis and one had no evidence of brain disease. The corneomandibular reflex, when found to be prominent, reflects an exaggeration of the normal. Therefore one may consider the corneomandibular hyper-reflexia as possibly due to disease of the corticobulbar system.

    http://archopht.jamanetwork.com/article.aspx?articleid=627241

    The corneomandibular reflex, or von Sölder phenomenon, is an automatic, involuntary movement of the mandible elicited by touching the cornea. This phenomenon is helpful in diagnosis of supranculear lesions of the trigeminal nerve. It simply requires observation of the relaxed and slightly opened jaw when the cornea is stroked with a cotton wisp, and it can be handily included in the testing of corneal sensation. A prominent deviation of the jaw, the result of homolateral contraction of the external pterygoid muscle, constitutes a positive response.

    http://archneur.jamanetwork.com/article.aspx?articleid=1674016

    Corneomandibular Reflex (Wartenberg Reflex) in Coma - A Rarely Elicited Sign

     A 52-year-old man underwent emergent surgery for a dissecting aneurysm of aorta type A (dissection of ascending, arch, and descending thoracic aorta) and remained intubated. Neurological examination revealed dilatation of the left pupil (6 mm) with no light response. Oculocephalic and oculovestibular reflexes were abolished. There was bilateral Babinski sign and bilateral decerebrate posture after pain stimuli. Stimulation for testing the corneal reflex elicited a normal direct response, an absent consensual response, and a horizontal movement of the mandible to the contralateral side (corneomandibular reflex [Wartenberg reflex]) ( ) on both sides. Neuroimaging showed a massive cerebral infarct. The patient died 7 days after the initial neurological consultation.

    Corneomandibular reflex consists of contralateral deviation of the mandible. It is suggested that a supranuclear lesion of the trigeminal nerve provokes an associated movement between the orbicularis oculi and the external pterygoid muscles.

    The reflex may be present in acute coma (especially if due to a structural lesion), cerebrovascular disease, multiple sclerosis, Parkinson disease, and amyotrophic lateral sclerosis. In acute unilateral supratentorial lesions such as infarcts or hemorrhages, the reflex is elicited contralaterally. In most cases with bilateral corneomandibular reflex, there have been bilateral brainstem pathological findings or a unilateral hemispheric lesion with secondary pressure on the brainstem.

    Discussion on Triphasic Waves

    EEG similarities between TWs and epileptiform sharp and slow wave complexes were already noted by Foley (1950), who thought that TWs could not always be clearly distinguished from ictal patterns associated with petit mal epilepsy (hence the term "blunted spike and wave" he used in describing TWs).
    As a matter of fact, differentiating NCSE from triphasic wave encephalopathy (metabolic or structural) may be difficult since TWs straddle the borders between epilepsy and encephalopathy (Kaplan 1999). Especially when TWs have a frequency higher than I Hz (Figure 4), the distinction between encephalopathy and NCSE may be particularly difficult (Kaplan 1999).
    Several investigators proposed EEG criteria in order to clearly differentiate "triphasic-like waves" in NCSE from nonepileptiform "true TWs" in encephalopathies. Litt et al. (1998) reported that monorhythmic TWs could be distinguished from epileptic patterns. An antero-posterior lag was considered to be specific for hepatic encephalopathy (Reiher 1970, Karnze and Bickford 1984), but it was later demonstrated that this time lag is neither a consistent feature of TWs nor of specific value regarding the type of metabolic encephalopathy (Fisch and Klass 1988). The appearance of TWs after noxious stimulation, which was considered a criterium to differentiate nonepileptiform "true TWs" from the epileptic pattern, has been recently challenged by the finding of stimulus-induced rhythmic, periodic or ictal discharges (SIRPIDs) (Hirsch et al. 2004). In a study conducted by Husain et al. (1999) epileptic "triphasic-like waves" in NCSE differed from nonepileptiform "true TWs" with an atypical morphology and variable periods of amplitude suppression between successive waveforms. Boulanger et al. (2006) conducted a retrospective study comparing EEG patterns in patients with diagnosis of NCSE and in patients with metabolic encephalopathy. Authors concluded that when compared with nonepileptiform "true TWs", epileptiform discharges associated with NCSE had a higher frequency, a shorter duration of phase one, extra spike components, and less generalized background slowing. Amplitude predominance of positive phase (wave 2) was similar. A phase lag was absent in all cases of NCSE but present in 40.8% of patients with nonepileptiform "true TWs." Noxious or auditory stimulation frequently increased the nonepileptiform "true TWs" (51%) without effect on epileptic "triphasic-like waves."
    Unfortunately none of these criteria, which would be of great utility, have been validated in an observer-blinded study (Bauer and Trinka 2010), so that definitive conclusions are still lacking.
    CLINICAL AND DIAGNOSTIC ASPECTS
    TWs may be encountered in many conditions, especially in metabolic/toxic disorders, but also in structural encephalopathies, and "triphasic-like waves" may occur during status epilepticus. The most common metabolic/toxic disturbances associated with this pattern are hepatic failure, renal failure, and anoxia. Other metabolic disorders which must be taken into account are hyponatremia, hypernatremia, hypercalcamia, and hypoglycaemia. Sporadic TWs may also occur in stroke, cerebral tumors, and elderly subjects with clinically advanced dementia. Physical and neurological examinations usually show a decline of consciousness ranging from mild confusion to stupor and coma with decreased responsiveness. Postanoxic TWs are frequently associated with myoclonus, whereas TWs during hepatic or renal failure may be accompanied by asterixis, a neurological sign consisting of recurrent sudden loss of muscle tone in the outstretched and dorsiflexed hands.
    The following laboratory studies may be useful to determine the presence of a metabolic encephalopathy: electrolytes, liver function tests, blood urea urea nitrogen, creatinine, and lithium levels. When laboratory tests are not suggestive of a metabolic/toxic disorder and when neurological examination shows focal neurological deficits, neuroimaging studies (CT or MRI) should be performed to rule out a structural encephalopathy.
    The most useful way to distinguish between "triphasic-like waves" occurring during status epilepticus and nonepileptiform "true TWs" occurring during nonepileptic encephalopathies is to evaluate whether electroclinical improvement following benzodiazepine administration occurs.
    CLINICAL AND TECHNICAL TIPS FOR A CORRECT INTERPRETATION OF TRIPHASIC WAVES
    Improvement in EEG pattern after intravenous administration of benzodiazepine may occur in both NCSE and metabolic encephalopathies (Fountain and Waldman 2001, Brenner 2002), being therefore of limited utility in the differential diagnosis.
    As a matter of fact, instead of considering only EEG modification after benzodiazepine or antiepileptic drug administration, an electroclinical response should be taken into account. After intravenous antiepileptic drug or benzodiazepine administration a clearly marked clinical improvement may occur in NCSE; such a clinical improvement does not occur in metabolic encephalopathies. The clinical response to benzodiazepines should be considered when interpreting TWs.
    The evaluation of the patient's consciousness impairment is another clinical aspect which should be considered when interpreting TWs. In metabolic encephalopathies, the impairment of consciousness is mild or moderate when TWs are seen, almost never reaching the level of coma. On the other hand, patients with anoxic encephalopathy following cardiopulmonary arrest are often in deep coma, at the time when "triphasic-like waves" are recorded. The epileptic nature of TWs may be suspected if they are associated with spikes (which, however, may be absent in 31% of the cases [Boulanger et al. 2006]). There are still no valid criteria for a differential diagnosis between epileptic and nonepileptic TWs in coma following cardiopulmonary arrest (Bauer and Trinka 2010).
    As a consequence, it is essential to interpret the EEG recording always considering clinical features and laboratory data. When only EEG is taken into account, electroencephalographers should not be dogmatic in distinguishing metabolic periodic discharges from seizure-related periodic discharges, because such a distinction is often not possible (Chong and Hirsch 2005).
    CONCLUSION
    In conclusion, nonepileptic "true TWs" with sharply contoured morphology may resemble epileptic patterns encountered in NCSE and may lead to misinterpretation and overinterpretation of this pattern as epileptic "triphasic-like waves" if only EEG is considered. Both the electroclinical response to benzodiazepines and evaluation of consciousness impairment should be considered when interpreting TWs. Evaluating only the EEG without considering also clinical and laboratory findings is not only useless and meaningless, but it may even lead to serious consequences.